Neurology

Pipeline Therapeutics

Clinical-stage company developing first-in-class therapies for precision neuroregeneration including myelin restoration, synaptogenesis and axonal repair with applications in hearing loss and multiple sclerosis.

 

Red Tree Participation
Co-investor in Series C
Total Addressable Market

$20 billion+

Red Tree Board Member(s)
Red Tree Participation
Co-investor in Series C

Pipeline Therapeutics

Neurology
Total Addressable Market

$20 billion+

Red Tree Board Member(s)
Red Tree Participation
Co-investor in Series C